Latest Posts

All Posts

Michael Koeris' Journey from Grad Student to Entrepreneur: The Story of Sample 6

Posted by Tyler Ford on Jan 21, 2016 11:52:39 AM

In the third installment in our podcast series, we chat with new Addgene Board Member, Michael Koeris. Dr. Koeris did his graduate work in Professor Jim Collins' lab (then at Boston University, now at MIT) where he worked on understanding bacterial antibiotic resistance. During this time, Dr. Koeris and Professor Timothy Lu (a graduate student in the Collins' lab at the time) got the idea to engineer bacteriophage (viruses that infect bacteria) for use as antibiotics. To develop this idea, Drs. Koeris and Lu founded the biotech startup company, Novophage. As you'll hear Dr. Koeris explain however, the time was not right for the development of phage-based therapeutics. After a brief stint at the venture capital firm, Flagship Ventures, Koeris helped change Novophage's focus. The company went from developing therapeutics to developing phage-based tools for detecting pathogens in food products. Along the way, the company changed its name from Novophage to Sample 6.

Read More >

Topics: Career, Interview, Career Readiness, Podcast

An Interview with Connie Cepko - Gene Therapy, Plasmid Tools and Insights to Success

Posted by Tyler Ford on Dec 8, 2015 10:30:00 AM

We recently sat down with Addgene Board Member, depositor, and Harvard Medical School researcher Connie Cepko. Listen to the podcast below to hear all about the research being conducted in Professor Cepko's lab and to get some insight into her management and mentoring styles. If you'd like to learn more about Professor Cepko's recent work on developing GFP-activated proteins, read our recent blog post.

Read More >

Topics: Interview, Viral Vectors, Podcast

Addgene Welcomes John Doench to the Advisory Board

Posted by Tyler Ford on Aug 13, 2015 10:30:00 AM

The Addgene Advisory Board consists of prominent members of the bioscience and tech transfer communities who help guide and promote Addgene in its mission to make research easier. Addgene is excited to announce that we’ve added John G. Doench, PhD to the Advisory Board. John Doench is Associate Director of the Genetic Perturbation Platform at the Broad Institute and has worked with many Addgenies to help improve the understanding, curation, and explanation of our CRISPR resources. We recently sat down with Dr. Doench for an interview to help further introduce him to the Addgene community.

Read More >

Topics: Interview, Inside Addgene, CRISPR, Podcast

Subscribe to Our Blog